Interleukin-2 therapy after autologous bone marrow transplantation for hematologic malignancies

Semin Oncol. 1993 Dec;20(6 Suppl 9):41-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Bone Marrow Transplantation*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Hematologic Diseases / therapy*
  • Humans
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Lymphokine-Activated
  • Leukemia / therapy*
  • Lymphoma / therapy*
  • Recombinant Proteins / therapeutic use

Substances

  • Interleukin-2
  • Recombinant Proteins